| Program | |
| 09:00 | Coffee/tea & registration |
| 09:20 | Opening by NVBMB chair – prof. dr. Luc Brunsveld |
| Session 1 (Gene editing) – Moderator Roy van der Meel | |
| 09:30 | Prof. dr. John van der Oost (WUR) CRISPR-Cas – from biology to applications |
| 10:00 | Dr. Sabine Fuchs (UMC Utrecht & Hubrecht Institute) Prime Time |
| 10:30 | Prof. dr. Gerald Schwank (Zurich University Hospital) (to be confirmed) Title |
| 11:00 | Coffee break |
| Session 2 (Nucleic acid therapeutics) – Moderator Roy van der Meel | |
| 11:30 | Prof. dr. Rob Collin (Radboudumc) (to be confirmed) Title |
| 12:00 | Prof. dr. Ine Lentacker (Ghent University) Title |
| 12:30 | Speaker (Affiliation) (to be confirmed) Title |
| 13:00 | Lunch |
| Session 3 (Industry session) – Moderator Roy van der Meel | |
| 14:00 | Dr. Jenny van Asbeck-van der Wijst (CEO, Mercurna) Title |
| 14:30 | Dr. Stefaan de Koker (Vice President Discovery, eTheRNA immunotherapies) Title |
| 15:00 | Dr. Melvin Evers (Vice President of Research, uniQure) Title |
| 15:30 | Coffee break |
| 16:00 | Award ceremony 2023 NVBMB prize to dr. Roy van der Meel – prof. dr. Luc Brunsveld |
| 16:15 | Dr. Roy van der Meel (TU/e) Gene silencing in HSPCs with an apolipoprotein A1-based nanodelivery platform |
| 16:45 | Closing by the NVBMB chair – prof. dr. Luc Brunsveld |
| 17:00 | Reception |
- About NVBMB
- Speaker of the year
- Grants
- Prizes
- Membership
- Meetings
- Sections
- Young NVBMB
Program Fall Meeting 2023
